Search

Vinata B Lokeshwar

from North Augusta, SC
Age ~63
Get Report
Also known as:
Bal Lokeshwar, Vinata Y
Phone and address:
321 E Shoreline Dr, North Augusta, SC 29841
(305) 255-6091
Related to:
Soum D Lokeshwar, 30Balakrishna Lokeshwar
Connected to:
Milika Loketi, 34Corliss R Lokey, 61Felecia K Lokey, 65Jennifer A Lokey, 57Josh Lokey, 36Nicole A Lokey, 40Patrick Lokey, 72Rachel L Lokey, 52Abha V Lokhande, 54Anar S Lokhandwala, 66

Vinata Lokeshwar Phones & Addresses

  • 321 E Shoreline Dr, North Augusta, SC 29841 (305) 255-6091
  • 12615 112Th St, Miami, FL 33176 (305) 255-6091

Publications

Us Patents

Biomarkers For Detection And Diagnosis Of Head And Neck Squamous Cell Carcinoma

View page
US Patent:
8088591, Jan 3, 2012
Filed:
May 14, 2007
Appl. No.:
12/300523
Inventors:
Elizabeth J. Franzmann - Miami FL, US
Vinata B. Lokeshwar - Miami FL, US
Assignee:
University of Miami - Miami FL
International Classification:
G01N 33/574
US Classification:
435 723, 435 71
Abstract:
Novel, sensitive and specific markers and methods for diagnostics and monitoring of head and neck squamous cell carcinoma (HNSCC) are provided. Kits and methods for the use of hyaluronic acid, hyaluronidase and CD44 to diagnose HNSCC are described.

Salivary Soluble Cd44: A Molecular Marker For Head And Neck Cancer

View page
US Patent:
20050214880, Sep 29, 2005
Filed:
Mar 28, 2005
Appl. No.:
11/090705
Inventors:
Elizabeth Franzmann - Miami FL, US
Vinata Lokeshwar - Miami FL, US
Erika Reategui - Miami FL, US
Assignee:
University of Miami - Miami FL
International Classification:
C12Q001/68
G01N033/574
US Classification:
435007230, 435006000
Abstract:
A method of diagnosing head and neck squamous cell carcinoma (HNSCC) includes obtaining a sample form a subject and measuring soluble CD44 (solCD44). The sample may be a body fluid such as saliva. An elevated level of solCD44 in the sample relative to baseline from a normal population of subjects is indicative of the presence of HNSCC. The degree of elevation can be indicative of the severity of disease. The HNSCC can be detected in an early stage and also as a recurrence of the disease.

Hyaluronidase Inhibitors As Anti-Cancer Agents

View page
US Patent:
20100075918, Mar 25, 2010
Filed:
Dec 7, 2007
Appl. No.:
12/516571
Inventors:
Vinata B. Lokeshwar - Miami FL, US
International Classification:
A61K 31/7016
A61P 35/04
US Classification:
514 53
Abstract:
Specific inhibitors of hyaluronidase (HYA1-type hyaluronidase) are used to treat cancer, especially carcinoma and solid tumors, and/or precancerous conditions.

Biomarkers For Detection And Diagnosis Of Head And Neck Squamous Cell Carcinoma

View page
US Patent:
20120115165, May 10, 2012
Filed:
Dec 13, 2011
Appl. No.:
13/324526
Inventors:
Elizabeth J. Franzmann - Miami FL, US
Vinata B. Lokeshwar - Miami FL, US
Assignee:
UNIVERSITY OF MIAMI - Miami FL
International Classification:
G01N 33/573
G01N 33/577
G01N 33/566
US Classification:
435 74, 435 75, 435 794
Abstract:
Novel, sensitive and specific markers and methods for diagnostics and monitoring of head and neck squamous cell carcinoma (HNSCC) are provided. Kits and methods for the use of hyaluronic acid, hyaluronidase and CD44 to diagnose HNSCC are described.

Biomarkers For Detection And Diagnosis Of Head And Neck Squamous Cell Carcinoma

View page
US Patent:
20140024042, Jan 23, 2014
Filed:
Sep 24, 2013
Appl. No.:
14/034916
Inventors:
Vinata B. Lokeshwar - Miami FL, US
Assignee:
University of Miami, Office of Technology Transfer - Miami FL
International Classification:
G01N 33/574
US Classification:
435 74, 435 792
Abstract:
Novel, sensitive and specific markers and methods for diagnostics and monitoring of head and neck squamous cell carcinoma (HNSCC) are provided. Kits and methods for the use of hyaluronic acid, hyaluronidase and CD44 to diagnose HNSCC are described.

Methods For Detection And Evaluation Of Bladder Cancer

View page
US Patent:
6350571, Feb 26, 2002
Filed:
Mar 10, 1999
Appl. No.:
09/265604
Inventors:
Vinata B. Lokeshwar - Miami FL, 33176
Henry T. Pham - Houston TX, 77081
International Classification:
C12Q 100
US Classification:
435 4, 435 71, 435 74, 435 772, 435810, 436 64
Abstract:
The present invention relates to novel methods for detecting and evaluating bladder cancer. The methods of the present invention are based on the discovery that normalized amounts of hyaluronic acid (HA) and hyaluronidase (HAase) are diagnostic markers for the detection of bladder cancer, evaluation of its grade, monitoring of the efficacy of its treatment, and tumor recurrence.

Biomarkers For Detection And Diagnosis Of Head And Neck Squamous Cell Carcinoma

View page
US Patent:
20160341728, Nov 24, 2016
Filed:
Aug 3, 2016
Appl. No.:
15/227382
Inventors:
- Miami FL, US
Vinata B. Lokeshwar - Miami FL, US
International Classification:
G01N 33/574
G01N 33/573
Abstract:
Novel, sensitive and specific markers and methods for diagnostics and monitoring of head and neck squamous cell carcinoma (HNSCC) are provided. Kits and methods for the use of hyaluronic acid, hyaluronidase and CD44 to diagnose HNSCC are described.
Control profile
Vinata B Lokeshwar from North Augusta, SC, age ~63 Get Report